Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xenon Pharmaceuticals Inc. - Common Shares
(NQ:
XENE
)
58.35
+0.81 (+1.41%)
Streaming Delayed Price
Updated: 2:58 PM EDT, Apr 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenon Pharmaceuticals Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
↗
December 12, 2022
Via
Benzinga
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
↗
December 06, 2022
Via
Benzinga
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)
December 02, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Where Xenon Pharmaceuticals Stands With Analysts
↗
November 28, 2022
Via
Benzinga
Analyst Sees This Epilepsy Player As 'M&A Sweet Spot'
↗
October 19, 2022
Via
Benzinga
Xenon Pharmaceuticals to Present at the Bank of America Securities Biotech SMID Cap Conference 2022
November 30, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
↗
November 29, 2022
Xenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 92 Tuesday, up from 89 a day earlier.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
↗
November 28, 2022
Via
Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
↗
October 11, 2022
Within the last quarter, Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings:
Via
Benzinga
Analyst Ratings for Xenon Pharmaceuticals
↗
August 29, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
↗
August 11, 2022
Within the last quarter, Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings:
Via
Benzinga
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
November 09, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing
↗
November 09, 2022
Biotech stocks were hammered Wednesday, including several that had good news.
Via
Investor's Business Daily
Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For November 8, 2022
↗
November 08, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Via
Benzinga
Earnings Preview: Xenon Pharmaceuticals
↗
November 07, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Xenon...
Via
Benzinga
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
November 07, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Announces Launch of XEN1101 Phase 3 Program with Initiation of X-TOLE2 Clinical Trial in Patients with Focal Onset Seizures
November 03, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
↗
November 01, 2022
As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends.
Via
InvestorPlace
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
November 01, 2022
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Swing Trading Stock Watchlist For The Week Of Sept. 6
↗
September 04, 2022
The overall stock market health is poor. I created a watchlist this week mainly to see how many stocks were forming quality contraction or cup-and-handle patterns. Let's take a look.
Via
Talk Markets
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
↗
August 29, 2022
Xenon Pharmaceuticals Inc’s (NASDAQ: XENE) epilepsy candidate, XEN1101, is currently in phase III trials and “looks poised to be a blockbuster,” according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
↗
August 29, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
↗
October 19, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Xenon Pharmaceuticals
↗
August 11, 2022
Analysts have provided the following ratings for Xenon Pharmaceuticals (NASDAQ:XENE) within the last quarter:
Via
Benzinga
Xenon Pharmaceuticals: Q2 Earnings Insights
↗
August 09, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 9, 2022
↗
August 09, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Outlook For Xenon Pharmaceuticals
↗
August 08, 2022
Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022
↗
July 21, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
↗
June 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
